BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24091085)

  • 41. Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection.
    Espy N; Pérez-Sautu U; Ramírez de Arellano E; Negredo A; Wiley MR; Bavari S; Díaz Menendez M; Sánchez-Seco MP; Palacios G
    J Infect Dis; 2018 May; 217(12):1952-1956. PubMed ID: 29584885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crimean-Congo hemorrhagic fever: a first case from Abbottabad, Pakistan.
    Saleem J; Usman M; Nadeem A; Sethi SA; Salman M
    Int J Infect Dis; 2009 May; 13(3):e121-3. PubMed ID: 19008137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
    Oestereich L; Rieger T; Neumann M; Bernreuther C; Lehmann M; Krasemann S; Wurr S; Emmerich P; de Lamballerie X; Ölschläger S; Günther S
    PLoS Negl Trop Dis; 2014 May; 8(5):e2804. PubMed ID: 24786461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of a new clinical severity scoring index for Crimean-Congo Hemorrhagic fever.
    Kalın G; Metan G; Demiraslan H; Doganay M
    J Chemother; 2015; 27(6):353. PubMed ID: 25360564
    [No Abstract]   [Full Text] [Related]  

  • 45. Crimean Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report.
    Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
    Scand J Infect Dis; 2009; 41(5):378-80. PubMed ID: 19343611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia.
    Sharifi-Mood B; Alavi-Naini R; Metanat M; Mohammadi M; Shakeri A; Amjadi A
    Trop Doct; 2013 Apr; 43(2):49-53. PubMed ID: 23796671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Crimean-Congo hemorrhagic fever.
    Ergonul O
    Antiviral Res; 2008 Apr; 78(1):125-31. PubMed ID: 18096251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations.
    Arda B; Aciduman A; Johnston JC
    J Med Ethics; 2012 Feb; 38(2):117-20. PubMed ID: 21994465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ribavirin in crimean-congo hemorrhagic fever: primum non nocere.
    Ergönül O; Celikbaş A; Dokuzoğuz B; Eren S; Baykam N; Esener H
    Clin Infect Dis; 2009 Nov; 49(10):1621-2. PubMed ID: 19857172
    [No Abstract]   [Full Text] [Related]  

  • 50. [Respiratory lesions in Congo-Crimean hemorrhagic fever].
    Sannikova IV; Pacechnikov VD; Maleev VV
    Ter Arkh; 2007; 79(11):20-3. PubMed ID: 18219967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crimean Congo hemorrhagic fever: requires vigilance and not panic.
    Bajpai S; Nadkar MY
    J Assoc Physicians India; 2011 Mar; 59():164-7. PubMed ID: 21751625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002.
    Athar MN; Baqai HZ; Ahmad M; Khalid MA; Bashir N; Ahmad AM; Balouch AH; Bashir K
    Am J Trop Med Hyg; 2003 Sep; 69(3):284-7. PubMed ID: 14628945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis.
    Ascioglu S; Leblebicioglu H; Vahaboglu H; Chan KA
    J Antimicrob Chemother; 2011 Jun; 66(6):1215-22. PubMed ID: 21482564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis.
    Soares-Weiser K; Thomas S; Thomson G; Garner P
    BMC Infect Dis; 2010 Jul; 10():207. PubMed ID: 20626907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nosocomial infection of Crimean-Congo haemorrhagic fever in eastern Iran: case report.
    Chinikar S; Shayesteh M; Khakifirouz S; Jalali T; Rasi Varaie FS; Rafigh M; Mostafavi E; Shah-Hosseini N
    Travel Med Infect Dis; 2013; 11(4):252-5. PubMed ID: 23266037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crimean-Congo hemorrhagic fever in Southeast of Iran.
    Alavi-Naini R; Moghtaderi A; Koohpayeh HR; Sharifi-Mood B; Naderi M; Metanat M; Izadi M
    J Infect; 2006 May; 52(5):378-82. PubMed ID: 16182370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crimean-congo haemorrhagic fever in pregnancy and in newborn: a case with a unique clinical course.
    Ünlüsoy-Aksu A; Havali C; Tapisiz A; Aktaş F; Ezgu F
    J Obstet Gynaecol; 2014 May; 34(4):360. PubMed ID: 24484082
    [No Abstract]   [Full Text] [Related]  

  • 58. Crimean-Congo hemorrhagic fever.
    Mardani M; Keshtkar-Jahromi M
    Arch Iran Med; 2007 Apr; 10(2):204-14. PubMed ID: 17367225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy of oral ribavirin on clinical and laboratory parameters inCrimean-Congo hemorrhagic fever: an observational study from Turkey.
    Ertem G; Sönmezer MÇ; Temoçin F; Ataman Hatipoğlu Ç; Tülek N; Oral B
    Turk J Med Sci; 2016 Nov; 46(5):1407-1414. PubMed ID: 27966306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Unexpected Fatal CCHF Case and Management of Exposed Health Care Workers.
    Guven G; Talan L; Altintas ND; Memikoglu KO; Yoruk F; Azap A
    Int J Infect Dis; 2017 Feb; 55():118-121. PubMed ID: 28069471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.